Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Abo-Incompatibility

Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation

Abstract

Aside from causing hemolytic reactions the ABO blood group system does not have an impact on outcome after allogeneic bone marrow or peripheral blood stem cell transplantation (SCT). However, only a few studies have addressed the effect of ABO incompatibility on the incidence of GVHD, time to engraftment, relapse and survival. Therefore, we performed a retrospective two-center analysis of 562 consecutive patients receiving allogeneic SCT, including 361 ABO-identical, 98 minor, 86 major and 17 bidirectional ABO-incompatible SCT. In multivariate analysis adjusted for potential confounders survival was significantly associated with ABO incompatibility (P = 0.006). Compared to ABO-identical SCT, bidirectional ABO incompatibility increased the risk significantly (RR, 2.8; 95% CI, 1.5–5.1; P = 0.0009), whereas survival of patients with minor (RR, 1.2; 95% CI, 0.9–1.7; P = 0.27), or major ABO-incompatible SCT (RR, 1.3; 95% CI, 0.9–1.8; P = 0.18) was not significantly different. RBC engraftment was delayed in major ABO-incompatible SCT (RR, 0.66; 95% CI, 0.51–0.85; P = 0.001). The incidence of acute GVHD (grade I–IV) was higher in minor ABO-incompatible SCT as compared to ABO identity (RR, 2.8; 95% CI, 1.3–5.9, P = 0.009). This difference was limited to mild GVHD; in moderate-to-severe GVHD (grade II–IV) no significant difference was found among the groups (P = 0.53). The relapse rate was not influenced by ABO incompatibility (P = 0.78). In conclusion, these results suggest that ABO incompatibility represents a risk factor not only for post-transplant hemolysis, but also for survival and the rate of mild GVHD after allogeneic SCT.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Klumpp TR . Immunohematologic complications of bone marrow transplantation Bone Marrow Transplant 1991 8: 159 170

    CAS  PubMed  Google Scholar 

  2. Lasky LC, Warkentin PI, Kersey JH et al. Hemotherapy in patients undergoing blood group incompatible bone marrow transplantation Transfusion 1983 23: 277 285

    Article  CAS  PubMed  Google Scholar 

  3. Petz LD . Hemolysis associated with transplantation Transfusion 1998 38: 224 228

    Article  CAS  PubMed  Google Scholar 

  4. Buckner CD, Clift RA, Sanders JE et al. ABO-incompatible marrow transplants Transplantation 1978 26: 233 238

    Article  CAS  PubMed  Google Scholar 

  5. Bensinger WI, Buckner CD, Thomas ED, Clift RA . ABO-incompatible marrow transplants Transplantation 1982 33: 427 429

    Article  CAS  PubMed  Google Scholar 

  6. Hershko C, Gale RP, Ho W, Fitchen J . ABH antigens and bone marrow transplantation Br J Haematol 1980 44: 65 73

    Article  CAS  PubMed  Google Scholar 

  7. Kalaycioglu M, Copelan E, Avalos B et al. Survival after ABO-incompatible allogeneic bone marrow transplant after a preparative regimen of busulfan and cyclophosphamide Bone Marrow Transplant 1995 15: 105 110

    CAS  PubMed  Google Scholar 

  8. Benjamin RJ, McGurk S, Ralston MS et al. ABO incompatibility as an adverse risk factor for survival after allogeneic bone marrow transplantation Transfusion 1999 39: 179 187

    Article  CAS  PubMed  Google Scholar 

  9. Bacigalupo A, Van Lint MT, Occhini D et al. ABO compatibility and acute graft-versus-host disease following allogeneic bone marrow transplantation Transplantation 1988 45: 1091 1094

    Article  CAS  PubMed  Google Scholar 

  10. Kunimasa J, Yurugi K, Ito K et al. Hemolytic reaction due to graft-versus-host (GVH) antibody production after liver transplantation from living donors: report of two cases Surg Today 1998 28: 857 861

    Article  CAS  PubMed  Google Scholar 

  11. Mielcarek M, Leisenring W, Torok-Storb B, Storb R . Graft-versus-host disease and donor-directed hemagglutinin titers after ABO-mismatched related and unrelated marrow allografts: evidence for a graft-versus-plasma cell effect Blood 2000 96: 1150 1156

    CAS  PubMed  Google Scholar 

  12. Stussi G, Seebach L, Muntwyler J et al. GVHD and survival after allogeneic bone marrow transplantation – a single center experience Br J Haematol 2001 113: 251 253

    Article  CAS  PubMed  Google Scholar 

  13. Farges O, Kalil AN, Samuel D et al. The use of ABO-incompatible grafts in liver transplantation: a life-saving procedure in highly selected patients Transplantation 1995 59: 1124 1133

    Article  CAS  PubMed  Google Scholar 

  14. Ishida H, Koyama I, Sawada T et al. Anti-AB titer changes in patients with ABO incompatibility after living related kidney transplantations: survey of 101 cases to determine whether splenectomies are necessary for successful transplantation Transplantation 2000 70: 681 685

    Article  CAS  PubMed  Google Scholar 

  15. Breimer ME, Brynger H, Le PJ et al. Blood group ABO-incompatible kidney transplantation biochemical and immunochemical studies of blood group A glycolipid antigens in human kidney and characterization of the antibody response (antigen specificity and antibody class) in O recipients receiving A2 grafts Transplant Proc 1987 19: 226 230

    CAS  PubMed  Google Scholar 

  16. West LJ, Pollock-Barziv SM, Dipchand AI et al. ABO-incompatible heart transplantation in infants New Engl J Med 2001 344: 793 800

    Article  CAS  PubMed  Google Scholar 

  17. Rydberg L . ABO-incompatibility in solid organ transplantation Transfus Med 2001 11: 325 342

    Article  CAS  PubMed  Google Scholar 

  18. Auchincloss HJ, Sachs DH . Xenogeneic transplantation Annu Rev Immunol 1998 16: 433 470

    Article  CAS  PubMed  Google Scholar 

  19. Galili U . Interaction of the natural anti-Gal antibody with alpha-galactosyl epitopes: a major obstacle for xenotransplantation in humans Immunol Today 1993 14: 480 482

    Article  CAS  PubMed  Google Scholar 

  20. Benjamin RJ, Antin JH . ABO-incompatible bone marrow transplantation: the transfusion of incompatible plasma may exacerbate regimen-related toxicity Transfusion 1999 39: 1273 1274

    Article  CAS  PubMed  Google Scholar 

  21. Heal JM, Blumberg N . The second century of ABO: and now for something completely different Transfusion 1999 39: 1155 1159

    Article  CAS  PubMed  Google Scholar 

  22. Lee JH, Lee KH, Kim S et al. Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation Bone Marrow Transplant 2000 25: 179 184

    Article  CAS  PubMed  Google Scholar 

  23. Gmür JP, Burger J, Schaffner A et al. Pure red cell aplasia of long duration complicating major ABO-incompatible bone marrow transplantation Blood 1990 75: 290 295

    PubMed  Google Scholar 

  24. Matsui T, Shimoyama T, Matsumoto M et al. ABO blood group antigens on human plasma von Willebrand factor after ABO-mismatched bone marrow transplantation Blood 1999 94: 2895 2900

    CAS  PubMed  Google Scholar 

  25. Szulman AE . The histological distribution of blood group substances A and B in man J Exp Med 1960 111: 785 799

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Eastlund T . The histo-blood group ABO system and tissue transplantation Transfusion 1998 38: 975 988

    Article  CAS  PubMed  Google Scholar 

  27. Klumpp TR, Fairclough D, Ritz J, Soiffer R . The effect of minor ABO mismatches on the incidence of graft-versus-host disease after allogeneic bone marrow transplantation Transplantation 1994 57: 780

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by grants from the Swiss National Science Foundation (4046–058668/1) and the Julius-Müller Stiftung to JDS and a grant from the Heuberg Stiftung to GS.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stussi, G., Muntwyler, J., Passweg, J. et al. Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 30, 87–93 (2002). https://doi.org/10.1038/sj.bmt.1703621

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1703621

Keywords

This article is cited by

Search

Quick links